Schechter D, Fields M, Laufer A
Br J Exp Pathol. 1975 Oct;56(5):466-70.
Experimental amyloidosis was induced in mice with repeated injections of complete Freund's adjuvant (CFA) reinforced with bacterial vaccine. BAPN administered in a mixture with CFA or on its own before the injection of CFA reduced the incidence of amyloidosis. The reduction in the incidence of amyloidosis following the administration of BAPN may be due to its inhibitory effect on the oxidative deamination of amino acids, which presumably inhibit cross-linking of amyloid fibrils or interfere with metabolic pathways which involve the formations of mucopolysaccharide formation. It is suggested that the defective formation of the mucopolysaccharide-amyloid protein complex inhibits amyloid deposition and induces the activity of beta glucuronidase observed in the present study. The reduced incidence of amyloidosis following BAPN adminsitration cannot be due to lysosomal enzyme degradation of the amyloid as the activity of cathepsin D and acid phosphatase is decreased during this process.
通过反复注射用细菌疫苗强化的完全弗氏佐剂(CFA)在小鼠中诱导实验性淀粉样变性。在注射CFA之前,将β-氨基丙腈(BAPN)与CFA混合给药或单独给药可降低淀粉样变性的发生率。BAPN给药后淀粉样变性发生率的降低可能是由于其对氨基酸氧化脱氨基的抑制作用,这可能抑制了淀粉样纤维的交联或干扰了涉及粘多糖形成的代谢途径。有人提出,粘多糖-淀粉样蛋白复合物形成缺陷会抑制淀粉样蛋白沉积,并诱导本研究中观察到的β-葡萄糖醛酸酶活性。BAPN给药后淀粉样变性发生率的降低并非由于淀粉样蛋白的溶酶体酶降解,因为在此过程中组织蛋白酶D和酸性磷酸酶的活性降低。